NovaDx (US) cedes Chondrex rights to SmithKline Beecham:
This article was originally published in Clinica
Executive Summary
NovaDx (US) has granted SmithKline Beecham first refusal to an exclusive licence for its arthritis test, Chondrex. NovaDx (Canada) purchased its US parent in February in a reverse takeover (see Clinica No 642, p 14).